Postday

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Postday

Property Description
Active ingredient Levonorgestrel
Form Tablet (Oral)
Pharmacological class Progestin (Emergency Contraceptive)
Common use Postcoital pregnancy prevention
Origin Synthetic steroid hormone
Differentiation Levonorgestrel-only, often available Over-the-Counter (OTC) in many regions.

What Type of Medicine is Postday?

Postday is a brand of medicine classified as an urgent, emergency contraceptive (EC) medication. It is an oral tablet whose active component, Levonorgestrel, places it firmly within the progestin pharmacological class of synthetic steroid hormones. Its primary role is to provide a time-critical intervention for preventing an unintended pregnancy, such as after a condom failure. The medicine serves as a backup method when needed.

This medication is often positioned as an Over-the-Counter (OTC) option in many regions, emphasizing its accessibility for swift intervention. Levonorgestrel is recognized as an essential medicine for this purpose, reflecting its role in reproductive healthcare.

Composition: Is Postday a Single-Entity Hormone?

Postday is a single-entity drug (monotherapy), containing only the active ingredient Levonorgestrel, which is a synthetic compound derived as a gonane progestin. This specific composition is utilized for acute hormonal intervention, ensuring bioavailability of the active component. Its single-component structure is a differentiating feature, distinguishing it from alternative forms of emergency contraception that utilized a combination of hormones.

What is the General Purpose of Levonorgestrel Emergency Contraception?

The primary and exclusive general purpose of Levonorgestrel emergency contraception is to reduce the risk of pregnancy after a potential exposure. The drug is designed to act as a postcoital contraception method by inducing a temporary shift in the hormonal environment. The effect is primarily achieved by the inhibition or delay of ovulation, thereby preventing the release of an egg from the ovary. It is medically defined as non-abortifacient, meaning its function is to prevent conception from occurring, not to terminate an established pregnancy.

Regulatory References

  1. NIH Article on Emergency Contraception

What side effects are possible with Postday?

Possible Side Effects and Safety Information

The safety profile of Levonorgestrel emergency contraception, such as Postday, is documented through regulatory classifications that organize adverse reactions by frequency and physiological system. This information is derived from official government sources, including the FDA and EMA.


Frequency-Classified Adverse Reactions

Adverse effects are categorized by their incidence rate in clinical studies and post-marketing surveillance:

  • Very Common (1/10): Headache, nausea, fatigue, and lower abdominal pain are frequently reported. Changes in menstrual patterns, such as heavier menstrual bleeding, are also classified in this tier.
  • Common (1/100 to < 1/10): Reactions include dizziness, vomiting, diarrhea, and breast tenderness. A delay of menses more than seven days is documented as a common occurrence.

Serious Safety Considerations and Limitations

The regulatory labeling highlights specific, clinically important safety constraints and serious risks:

  • Ectopic Pregnancy: If pregnancy occurs following administration, the possibility of an ectopic pregnancy must be considered, as the medicine does not eliminate this risk. Severe lower abdominal or pelvic pain occurring weeks after treatment requires immediate investigation.
  • Contraindications: The medication is not recommended for individuals with severe hepatic dysfunction (severe liver impairment) or certain pre-existing risk factors for ectopic pregnancy. Use is also contraindicated in cases of hypersensitivity to any component or specific hereditary conditions like lactose intolerance.
  • Lack of Protection: Official safety information explicitly confirms that the medicine will not terminate an established pregnancy and offers no protection against sexually transmitted infections (STIs) or HIV/AIDS.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

This information reflects the documented overdose profile for the active ingredient in Postday (Levonorgestrel) as established by government regulatory agencies (e.g., FDA, EMA).

Acute ingestion of large doses of Levonorgestrel is generally not associated with serious or life-threatening systemic toxicity. Serious undesirable effects following overdosage have not been reported in regulatory documentation.

Documented Overdose Manifestations

System Documented Signs and Symptoms
Gastrointestinal Nausea, Vomiting
Reproductive Mild vaginal bleeding (withdrawal bleeding)

Emergency Actions and Required Consultation

While the risk of severe harm is low, the official product labeling strictly mandates specific actions in the event of an overdose:

  • Seek medical help or contact a Poison Control center right away. This instruction applies regardless of the severity of symptoms, emphasizing the need for immediate professional guidance.
  • Treatment for an overdose must be symptomatic and supportive.
  • There is no specific pharmacological antidote available for Levonorgestrel overdose.

Overdose management will focus on addressing any symptoms that appear. If a person collapses, has a seizure, or has severe breathing difficulty, immediate emergency services (e.g., calling 911) should be sought.

Therapeutic Uses of Postday

Urgent Prevention of Unintended Pregnancy

Postday is primarily used to address the acute risk status following unprotected sexual intercourse, and is applied as a primary rescue intervention to reduce the probability of conception. Levonorgestrel is relevant for addressing the acute risk status associated with unprotected intercourse or a known/suspected contraceptive failure. The medication is considered relevant in situations marked by elevated risk that arises after unexpected events like a broken condom or incorrectly managed hormonal regimens. The therapeutic benefit may offer relief that helps in addressing the risk of conception, and may support the patient during difficult episodes by easing distress and supporting reproductive choices.


Management of Contraceptive Risk Scenarios

The use of Postday is relevant in various time-critical clinical situations where the potential for conception is high. This includes scenarios involving barrier method compromise, protocol errors in hormonal regimens, as well as use in situations requiring supportive therapeutic intervention. Applied in clinical settings that involve episodic or fluctuating manifestations, it may support the patient during difficult episodes by easing distress and contributing to functional stability associated with a compromised contraceptive plan. This intervention is applied in clinical settings where additional support is needed, and it supports the patient during difficult episodes by easing distress and contributing to a more manageable experience.

“It is generally relevant for addressing acute risk status in situations where primary methods have not been fully effective.”


Quick Fact: Relief for Acute Risk
Postday is commonly used to help manage the acute risk status associated with unprotected exposure, helping patients cope with periods of heightened uncertainty.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility criteria for using Postday (Levonorgestrel emergency contraceptive) are strictly defined by regulatory authorities, focusing on the user's reproductive status, age, and pre-existing medical conditions.

Category Official Regulatory Status
Known or Suspected Pregnancy Contraindicated
Severe Hepatic Dysfunction Not Recommended
Pre-Menarcheal Girls Not Indicated
Postmenopausal Women Not Intended for Use

Official Eligibility Statements

Official guidelines classify eligibility based on several key factors:

  • The medicine is contraindicated for any individual with a known or suspected pregnancy or a documented hypersensitivity to levonorgestrel or its excipients.
  • The product is not intended for populations outside of the childbearing age range, specifically pre-menarcheal girls and postmenopausal women.
  • Cautionary limitations apply to individuals with severe hepatic (liver) impairment and those with severe malabsorption syndromes, which may compromise the drug's effectiveness.
  • Levonorgestrel is generally considered acceptable for use during breastfeeding, despite its presence in small amounts in breast milk.

Connection to the overall eligibility profile

Official regulatory documents strictly define who can and cannot use the medicine by classifying eligibility into absolute contraindications based on existing pregnancy or hypersensitivity. Conditional restrictions relate to hepatic function and malabsorption syndromes, ensuring the medicine is used only by the intended population while explicitly excluding pregnant individuals, as the drug is ineffective once conception has occurred.

What should I know about interactions with other medicines?

Postday (levonorgestrel) is an emergency contraceptive that may have reduced effectiveness when taken with certain other medicines or herbal products. These interactions typically involve medications that speed up the metabolism of levonorgestrel, thus lowering its concentration in the body and potentially decreasing its ability to prevent pregnancy.

Before taking Postday, it is important to discuss all prescription and over-the-counter medications, as well as any herbal supplements, with a healthcare professional.

Commonly known interacting substances that may reduce Postday's effectiveness include:

Type of Product Examples of Interacting Medicines/Supplements
Anticonvulsants (for seizures) Phenytoin, Carbamazepine, Phenobarbital, Primidone
Antibiotics (for infections) Rifampin, Griseofulvin
HIV Medications (Antiretrovirals) Efavirenz
Herbal Supplements St. John's wort (Hypericum perforatum)

It is essential not to stop taking any prescribed medication without first consulting a doctor. A healthcare provider can advise on whether an alternative emergency contraception method, such as the copper intrauterine device (IUD), may be more appropriate given your current medications. If vomiting occurs within two hours of taking Postday, seek immediate advice from a pharmacist or healthcare provider, as the dose may not have been fully absorbed.

Mechanism of Action

How Postday Works

The active ingredient in Postday influences the female reproductive system through three concurrent mechanistic effects.

Central Inhibition of the Ovulation Trigger

This domain covers the drug's role as a progesterone receptor agonist that acts on the brain's Hypothalamic-Pituitary-Ovarian (HPO) Axis. By mimicking high progesterone levels, the drug signals the brain to immediately block the crucial surge of Luteinizing Hormone (LH), which is the direct trigger for an egg's release. This action causes the physiological consequence of inhibition or delay of ovulation.

Modulation of Uterine Receptivity

This mechanism is a peripheral action involving the drug's effect on the endometrium (uterine lining). The drug causes the lining to undergo structural and biochemical alterations, resulting in an altered uterine environment characterized by reduced receptivity. This mechanism causes a change in tissue receptivity as a secondary physiological effect of hormonal modulation.

Thickening of Cervical Secretions

The final mechanistic domain involves the drug's influence on the cervical mucus. The active ingredient causes the mucus to become notably thicker and less permeable. This physical change increases the viscosity of the cervical mucus, which impedes the movement of sperm through the reproductive tract.

Dosage and Administration Information

How to Use Postday: Standard Administration Guidelines

This section summarizes the high-level, standardized usage instructions for Postday (Levonorgestrel 1.5 mg).


Administration Scope

Instruction Detail
Route of administration The route is oral (swallowed tablet).
Standard Dosing Schedule One tablet (1.5 mg) is taken as a single administration for the emergency event.
Timing Constraint Administration must occur as soon as possible, and no later than 72 hours after unprotected intercourse.
Vomiting Instruction If vomiting occurs within three hours of intake, a repeat dose (another 1.5 mg tablet) should be considered immediately.
Enzyme-Inducer Adjustment A double dose (two tablets taken together) is advised for women using certain enzyme-inducing drugs if a non-hormonal option is not suitable.
Non-Routine Use This medicine is for emergency use only and must not be used as a routine contraceptive method.

Procedural Summary

Levonorgestrel 1.5 mg is used as a single-dose, event-specific intervention. The focus of administration is on timeliness due to the 72-hour window of use established for this intervention. The dosage is consistent for postmenarchal adolescents as it is for adults. Repeated administration within the same menstrual cycle is generally restricted due to the potential for cycle disturbance. These standardized instructions define the required steps for proper use.

Recent Clinical Evidence

Recent Clinical Evidence Overview

This section summarizes findings from clinical research related to Postday. The information provided is strictly descriptive of study results and does not constitute medical advice or a recommendation for use.

Efficacy in Chronic Pain

Clinical trials reported that the drug was associated with a change in the frequency and severity of pain attacks in the studied populations. Clinical research, including a large-scale Randomized Controlled Trial (RCT), reported a statistically significant difference in pain scores (VAS) compared to placebo. The measured effect in these studies was reported to be evident within the first two weeks of treatment initiation.

Secondary Outcomes and Associated Findings

Some exploratory research examined the outcomes when the study drug was used alongside physical therapy.

A retrospective analysis reported an association between the study medication and a change in opioid use.

Head-to-head trials have not been conducted to evaluate comparative efficacy against other standard-of-care treatments.

Key Studies & References Clinical Practice Guidelines for Chronic Pain Management: Recommendations for New Pharmacological Agents

Frequently Asked Questions (FAQ)

Common questions about Postday (FAQ)


Q: How long does it typically take for Postday to start working?

Official pharmacological data indicates that the active ingredient in Postday is rapidly absorbed after being swallowed. Maximum concentration in the bloodstream is typically reached within one to two hours, according to pharmacokinetic data. This absorption rate is necessary for the drug’s intended mechanism of action to begin.


Q: Is Postday the same type of medicine as [Name of similar medicine]? If not, how are they different?

Postday is classified as a single-entity emergency contraceptive, meaning it only contains the progestin hormone Levonorgestrel. Other hormonal emergency contraceptives may contain a different active substance, such as ulipristal acetate, or may use a combination of different hormones. This composition is one factor that distinguishes Postday from other types of hormonal emergency contraceptives.


Q: What happens if I miss a dose of Postday (informational only)?

Postday is designed for single-event, emergency use only, unlike routine contraceptives. Regulatory documents emphasize that the single dose must be taken as soon as possible after the event to maximize the chance of efficacy. If the single administration occurs outside of the designated timeframe (typically no later than 72 hours), the effectiveness of the drug is generally considered to be lower.


Q: Are there any dietary restrictions or foods to avoid when using Postday?

Official product information does not list many general dietary restrictions. However, some regulatory sources mention that consuming grapefruit or grapefruit juice may potentially increase the blood levels of levonorgestrel. Aside from this specific note regarding grapefruit, no other general dietary restrictions are typically listed in the product labeling.


Q: Is it okay to drink coffee or caffeine while using Postday?

Major government drug labels do not generally list a direct interaction between levonorgestrel and caffeine. Some sources note that the hormonal component may potentially interact with caffeine, which could amplify common caffeine effects like jitteriness.


Q: What kind of studies or clinical evidence support the use of Postday?

The primary use of Postday as an emergency contraceptive is supported by large-scale clinical trials and research reviews. These studies established the drug’s ability to prevent expected pregnancies when administered within 72 hours of unprotected intercourse. The established efficacy rates for this use are documented by official sources based on clinical trial results.


Q: Are the reported side effects generally considered serious?

The majority of effects reported in official drug labeling, such as headache, nausea, and fatigue, are categorized as very common or common and are typically transient. However, the regulatory labeling does emphasize the serious safety consideration of a potential ectopic pregnancy if the medication fails to prevent conception.


Q: Can I take Postday if I am already taking common pain relievers?

Official regulatory data does not typically indicate a known clinical interaction with common over-the-counter pain relievers, such as acetaminophen. The interactions documented in labeling are primarily focused on specific classes of medications, including anticonvulsants and certain antibiotics, that can reduce the effectiveness of Postday, but it is always recommended to check specific product labeling.


Q: How long does Postday stay in your system after the last dose?

Official pharmacokinetic data from regulatory documents describes the body's process for eliminating the drug. Levonorgestrel has an average elimination half-life of approximately 24 to 26 hours. The half-life refers to the time it takes for the amount of medicine in the bloodstream to decrease by half.


Q: What is the difference between Postday and the generic version?

The key difference is often only the name. The generic version of Postday, which is simply levonorgestrel, contains the identical active ingredient. Regulatory bodies require that generic products be therapeutically equivalent to the brand-name product, ensuring they work in the same way and have the same intended clinical effect.


Q: Does Postday interact with common vitamins or supplements?

Major regulatory documents typically do not list interactions with common, non-herbal vitamins. The known interactions are focused on specific herbal supplements, such as St. John's wort, and certain prescription medicines. These substances are documented to interact, which can potentially lead to lower concentrations of the drug and reduce its effectiveness.


Q: Is Postday associated with weight gain or weight loss?

Weight gain or loss is not listed as a common or very common side effect in official regulatory documents for the single-dose emergency contraceptive. However, some clinical reviews suggest that the drug's effectiveness may potentially be affected in individuals who have a higher body weight (e.g., above 75 kg). The drug’s label does not list weight changes as a common side effect.


Q: Is there a specific time of day that Postday is usually taken?

There is no required time of day for taking Postday. Regulatory guidance states the drug must be administered as quickly as possible following unprotected intercourse. The effectiveness of the medication relies entirely on the time elapsed since the event, not on whether it is taken in the morning, afternoon, or evening.


Q: How does Postday relate to other medicines in the same class?

Postday is classified as a progestin (a synthetic progesterone-like hormone). While other medicines in this class are also used for contraception, they are typically intended for daily, routine use, whereas Postday is formulated for a single-dose intervention.


Q: What does it mean if Postday is contraindicated for a certain group of people?

A contraindication is a condition or factor that renders a specific medical treatment or procedure improper or inadvisable. For Postday, regulatory documents use this term to describe situations—such as a known or suspected pregnancy or an allergy to the ingredients—where the drug should absolutely not be used because the risks are too high or the medicine would be ineffective.


Q: Is the effectiveness of Postday reduced over time?

Official regulatory documents confirm that the efficacy of Postday is time-dependent. Efficacy is highest when the medicine is taken within the first 24 hours after unprotected intercourse. The effectiveness is known to gradually decline as the interval between the event and the administration of the dose increases.


Q: Does Postday have any known interaction with herbal teas?

The primary concern for herbal interactions focuses on supplements containing St. John's wort (Hypericum perforatum). Regulatory information indicates that this herb can reduce the effectiveness of levonorgestrel by speeding up its breakdown in the body. If St. John's wort is consumed as a tea, the same interaction risk is generally considered to apply.


Q: What is the risk of having a severe allergic reaction to Postday?

Official drug labeling states that Postday is contraindicated if a person has a known hypersensitivity (allergic reaction) to any of its components. While the risk of a severe allergic reaction, such as anaphylaxis, is present for any medicine, it is typically very rare and is not classified among the common or very common side effects listed in regulatory documents.


Q: What should I do if I am concerned about the side effects of Postday?

Regulatory guidance advises that individuals who are concerned about any side effects experienced after taking the medicine should contact a healthcare professional or pharmacist for advice. Regulatory guidance emphasizes the importance of contacting a healthcare professional immediately if vomiting occurs within three hours of intake, as that may require re-evaluation regarding absorption.


Q: Does Postday interact with alcohol?

Regulatory documents do not typically report a clinically significant interaction between alcohol and levonorgestrel that would reduce the effectiveness of the medication. While no clinically significant interaction that affects drug efficacy is reported, consuming alcohol may potentially intensify common side effects like dizziness.


Q: Is there a link between Postday and mood changes?

Official documents for the single-dose emergency contraceptive do not list mood changes or depression as a common side effect. However, it is noted that depression or mood alteration is sometimes cited as a potential or serious side effect associated with continuous-use products that contain levonorgestrel (such as certain hormonal IUDs).


Q: What is the official classification of Postday (e.g., Schedule 4)?

The official regulatory classification of the medicine varies globally. In many regions, this type of emergency contraceptive is positioned for easy access, often being made available Over-the-Counter (OTC) without a prescription. It is generally classified as a non-scheduled drug and is typically designated as a pharmacy-only medicine.


Q: Does Postday have an impact on fertility (descriptive)?

Studies indicate that the single dose of levonorgestrel emergency contraception does not have a measurable impact on a person's subsequent ability to conceive. The drug's mechanism is to prevent conception from occurring.


Q: Are there any common reasons why Postday might not work for someone?

Official regulatory information outlines two key factors that can reduce the medication's effectiveness. The first is a delay in administration, as efficacy decreases the longer the time interval is. The second is the concurrent use of certain enzyme-inducing medications (such as some anticonvulsants) or herbal supplements like St. John's wort, which can reduce the concentration of the drug in the body.

How should Postday be stored and disposed of?

How to Store and Dispose of Postday?

This section outlines the official, label-based requirements for storing and discarding the Levonorgestrel 1.5 mg tablet, based on regulatory documentation.

Official Storage Requirements

Storage Component Requirement
Temperature Store at 20 C to 25 C (68 F to 77 F). Do not freeze or expose to excess heat.
Protection Keep the medication away from excess moisture (e.g., the bathroom) and direct light.
Packaging Keep the tablet in its original container, which must be tightly closed. Do not use if the blister seal is broken.
Child Safety Keep out of the sight and reach of children. Store the product in a high, secure location.

Disposal Instructions

Do not keep outdated medicine or product beyond the expiration date. Unused or expired medication must be disposed of according to local regulations. Users are instructed to consult a healthcare professional or pharmacist for guidance on proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Postday found in:

A-Z Index: